Provider
QP66-20 Updates to Injectable Drug Authorization Requests
Program effective Date: Jul 22, 2020
Documents & Forms Results
Displaying 2311 - 2320 of 3629 results
Provider
QP64-20 Medical Drug Update for New to Market Viltolarsen
Program effective Date: Jul 22, 2020
Provider
QP68-20 MHCP Pharmacy Benefit Update - Eylea®, Iluvien®, Lucentis®, Ozurdex® ,Retisert™ and Yutiq®
Program effective Date: Jul 22, 2020
Provider
QP62-20 Medicaid Sleep Management – Home Sleep Studies
Program effective Date: Jul 22, 2020
Provider
QP63-20 MDH Guidance to Support Hospital Patients with Disabilities and Pediatric Patients
Program effective Date: Jul 22, 2020
Claims & Appeals
Provider
Non-Minnesota/Non-Par Provider Claim Adjustment Appeal Form
Provider
QP67-20 Commercial Pharmacy Benefit Exclusion for DurystaTM, Iluvien®, Retisert® and Yutiq®
Program effective Date: Jul 22, 2020
Provider
QP69-20 Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) Criteria: Risdiplam
Program effective Date: Jul 22, 2020
Provider
QP65-20 Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) Criteria: Satralizumab
Program effective Date: Jul 22, 2020
Provider
P48-20 CMS Issued Prior Authorization Requirements for Certain Hospital Outpatient Department (OPD) Services – Effective July 1, 2020
Program effective Date: Jul 01, 2020